BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
-0.0026 B
Last period Net income ,USD
What is Net income ?
Net profit is the amount of money that remains at the disposal of the company after deducting production and operating expenses, as well as taxes and other obligatory payments.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Net profit is the amount of money that remains at the disposal of the company after deducting production and operating expenses, as well as taxes and other obligatory payments.
BioNexus Gene`s Net income for the period ended 2023-09-30 is -0.0026 B USD
